Stock Analiz

Drdgold Ltd. DRD

Precious Metals · data as of November 13, 2026

$22.89Market cap $2.0B
Open the interactive analysis →

Drdgold Ltd. (DRD) is a materials company listed in the US with a market value of about $2.0B. In fiscal year 2026 it had revenue of $659M and net income of $251M, a net margin of 38.1%.

Its overall Stock Analiz score is 4.2 out of 5 (excellent). The strongest part is value (5/5); the weakest is shareholder returns (3/5).

Key numbers: a P/E of 7.9, a price to free cash flow of 15.7, 5-year revenue growth of 13% a year, a 5-year average ROIC of 21%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 70% above the current price.

Score: 4.2 / 5

Value5/5
Future growth4/5
Track record4/5
Financial health5/5
Shareholder returns3/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Checks not passed

  • 3-year free cash flow growth above 10% a year
  • ROE above 15%
  • Share count down over 3 years (buybacks)
  • Stock-based pay below 5% of revenue

Valuation

P/E (TTM)7.9
Forward P/E34.4
P/FCF15.7
P/S3.0
P/B4.0
EV/EBITDA5.2
PEG0.31
Dividend yield4.31%
FCF yield6.4%
Shareholder yield4.3%
Intrinsic value vs. price+70%

Growth and quality

Revenue growth (1 yr)29.3%
Revenue growth (5 yrs, per year)13.0%
EPS growth (5 yrs, per year)25.6%
FCF growth (3 yrs, per year)8.2%
Net margin (5-yr avg.)24.5%
ROIC (5-yr avg.)20.9%
Profitable years (of last 10)10
Years paying a dividend9

Financials, last 10 years

Fiscal year2026202520242023202220212020201920182017
Revenue$659M$443M$343M$290M$312M$368M$241M$195M$181M$179M
Net income$251M$126M$73M$68M$69M$101M$37M$6M$472178$1M
Free cash flow$127M$71M-$63M$27M$56M$82M$55M-$4M$8M-$5M
EPS (diluted)$2.89$1.45$0.84$0.78$0.79$1.16$0.42$0.06$0.01$0.01
Net margin38.1%28.5%21.3%23.3%22.0%27.3%15.2%2.8%0.3%0.6%
ROIC—24.0%17.1%17.2%18.5%27.6%15.1%3.5%3.2%-1.5%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

What is Drdgold’s P/E ratio?

About 7.9, based on the last twelve months of diluted earnings per share (forward P/E about 34.4).

Is Drdgold stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 70% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Drdgold pay a dividend?

Yes. The dividend yield is about 4.31%, and it has paid dividends for 9 years in our data.

Is Drdgold a good stock to buy?

We do not give buy or sell advice. Drdgold scores 4.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.